This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Stocks Rising on Unusual Volume

Albany Molecular Research

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Albany Molecular Research ( AMRI) is a contract research and manufacturing organization providing customers drug discovery, development and manufacturing services. This stock closed up 9.4% at $11.87 on Wednesday.

Wednesday's Volume: 1.03 million
Average Volume: 468,411
Volume % Change: 134%

Shares of AMRI ripped higher on Wednesday after Sterne Agee re-initiated the stock with a buy rating and $15 price target.

>>5 Stocks Set to Soar on Bullish Earnings

From a technical perspective, AMRI skyrocketed higher here right above its 50-day moving average at $10.64 with heavy upside volume. This move has pushed shares of AMRI into breakout territory, since the stock took out some near-term overhead resistance levels at $11.47 to $11.86. Shares of AMRI are now quickly moving within range of triggering an even bigger breakout trade. That trade will hit if AMRI manages to take out Wednesday's high at $12.14 and then once it clears its 52-week high at $12.50 with high volume.

Traders should now look for long-biased trades in AMRI as long as it's trending above either of those first-tier breakout levels at $11.86 or $11.47 and then once it sustains a move or close above $12.14 to $12.50 with volume that hits near or above 468,411 shares. If that breakout hits soon, then AMRI will set up to enter new 52-week-high territory above $12.50, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17.

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AMRI $17.73 0.74%
ESI $6.73 -0.88%
ICLR $70.60 0.10%
MLNX $44.87 -1.00%
YHOO $44.13 -0.69%


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs